In which clinical situations is there a good rationale for the use of proton therapy for GI cancers?

Topics: Radiation Oncology • Gastrointestinal Cancers

Should we give concurrent capecitabine?

Answer from: Radiation Oncologist at Academic Institution

The biology of smaller fraction size is dominant with re-RT. Unless everything in the high dose volume (includes margin) can take that dose with low risk, smaller fraction sizes are preferred. IMRT allows more control of where the dose goes and better sparing of nearby sensitive organs than protons ...

Comments

Radiation Oncologist at University of Cincinnati College of Medicine
I agree with all of the above. I would also add In...

Radiation Oncologist at Memorial Sloan-Kettering Cancer Center
Good point, agreed.

Radiation Oncologist at Karmanos Cancer Institute - McLaren Proton Therapy Center
@Christopher H. Crane makes excellent points on re...

Radiation Oncologist at Memorial Sloan-Kettering Cancer Center
So you are saying that IMPT can overcome the physi...

Radiation Oncologist at Florida International University - Herbert Wertheim College of Medicine
The applicability of proton therapy is where low d...

Related Questions